Hyponatremia Classification and Management Table
The evaluation and management of hyponatremia should be systematically organized by volume status, with specific laboratory parameters guiding diagnosis and treatment decisions. 1
Summary Table: Hyponatremia Classification and Management
| Volume Status | Typical Causes | Urine Sodium (mmol/L) | Urine Osmolality (mOsm/kg) | First-Line Management |
|---|---|---|---|---|
| Hypovolemic (CVP <5 cm H₂O) | • Cerebral salt wasting (CSW) • Diuretics • Adrenal insufficiency • GI losses • Burns |
>30 (renal losses) <30 (extrarenal losses) |
>100 | • Normal saline (50 mL/kg/day) • Salt supplementation (12 g/day) • Fludrocortisone for CSW |
| Euvolemic (CVP 6-10 cm H₂O) | • SIADH • Hypothyroidism • Hypocortisolism • Polydipsia |
>40 (SIADH) <30 (polydipsia) |
>100 (SIADH) <100 (polydipsia) |
• Fluid restriction (<800 mL/day) • Treat underlying cause • Consider vaptans for SIADH |
| Hypervolemic (CVP >10 cm H₂O) | • Congestive heart failure • Cirrhosis • Renal failure • Nephrotic syndrome |
<30 (CHF, cirrhosis) >30 (renal failure) |
>100 | • Fluid restriction • Loop diuretics • Treat underlying condition |
Key Diagnostic Parameters
Critical Laboratory Thresholds 1
- Serum sodium <131 mmol/L: Triggers comprehensive workup including serum/urine osmolality, urine electrolytes, and uric acid
- Urine sodium <30 mmol/L: 71-100% positive predictive value for saline responsiveness
- Urine sodium >40 mmol/L: Suggests SIADH in euvolemic patients
- Serum uric acid <4 mg/dL: 73-100% positive predictive value for SIADH (though may include CSW patients)
Volume Status Assessment 1
Physical examination alone has only 41% sensitivity and 80% specificity for determining volume status. Central venous pressure (CVP) provides more objective assessment:
- CVP <5 cm H₂O: Hypovolemic
- CVP 6-10 cm H₂O: Euvolemic
- CVP >10 cm H₂O: Hypervolemic
Treatment Approach by Severity
Severe Symptomatic Hyponatremia 1
For acute hyponatremia with severe symptoms (seizures, altered mental status, coma), correct 6 mmol/L over 6 hours using hypertonic saline, but do not exceed 8 mmol/L total correction in 24 hours. This prevents osmotic demyelination while reversing life-threatening cerebral edema.
Asymptomatic or Mild Symptoms 1
- Hypovolemic: Normal saline 50 mL/kg/day plus salt supplementation
- Euvolemic (SIADH): Fluid restriction to <800 mL/day
- Hypervolemic: Fluid restriction plus loop diuretics
Critical Pitfalls to Avoid
Do not rely on physical examination alone for volume status determination - it misclassifies patients 59% of the time. 1 Use CVP monitoring when available or combine multiple clinical parameters.
Do not measure ADH or natriuretic peptide levels - these have limited diagnostic value and conflicting data. 1 Focus instead on urine sodium, urine osmolality, and volume status assessment.
Distinguish CSW from SIADH carefully in neurosurgical patients - both present with natriuresis and hyponatremia, but CSW requires volume repletion while SIADH requires fluid restriction. 1 CVP <6 cm H₂O indicates CSW; CVP 6-10 cm H₂O suggests SIADH.
Special Considerations
Subarachnoid Hemorrhage Patients 1
Treat even mild hyponatremia (serum Na 131-135 mmol/L) due to increased risk of cerebral ischemia and poor outcomes. Hyponatremia in SAH patients increases odds of poor outcome 2.7-fold at 3 months.
Correction Rate Monitoring
Regardless of initial approach, monitor serum sodium every 2-4 hours during active correction to prevent exceeding 8 mmol/L increase in 24 hours, which risks osmotic demyelination syndrome.